TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | -5 | -8 | 13 | 187 | 245 | 71 |
| P | %wins | 0 | 50 | 50 | 50 | 50 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/09 10:58 | 1/30/09 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Grant Stuart | AL | O | SVP,CFO | P | 5 | 1.62 | 0 | 3 | 100 | 6 | -4 | 3 | -25 | 70 | 413 | 303 | |||||||||
8/4/08 18:47 | 8/4/08 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Grant Stuart | AL | O | SVP,CFO | P | 8 | 2.82 | 0 | 3 | New | 3 | D | -70 | -58 | -20 | -7 | 17 | 26 | 20 | 6 | -1 | -13 | 9 | -45 | -40 | 186 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |